Yersinosis-related reactive arthritis: diagnostic and treatment constraints (individual experience)

Main Article Content

O.I. Ivashkivskyi
T.A. Karasevska
M.B. Dzhus
H.L. Novytska


Reactive arthritis (ReA) remains an important problem in the practice of rheumatology, and is one of the most common types of acute arthritis in young people. The relevance of ReA is due to its high frequency, difficulties of diagnosis, a chronicity with an insufficiently effective treatment. The article discusses current literature data on Yersinia arthritis, features of pathogenesis, diagnosis and treatment. The occurrence of ReA is most often associated with gastrointestinal or urogenital infection, which precedes the development of joint syndrome. Among the ReAs associated with intestinal infection, Yersinia is quite common. Intestinal yersiniosis is severe, has a significant duration with a tendency to chronicity, involvement of various organs and systems in the pathological process. The features of Yersiniosis pathogens in combination with infectious conditions cause a wide variety of clinical manifestations. The disease has a frequent association with HLA-B27 antigen. Among the common clinical symptoms of ReA there are asymmetric arthritis of the lower extremities, sausage-like toe deformity, tendonitis, enthesitis (most commonly heel tendon enthesitis), and asymmetric sacroiliitis. The frequency and severity of extra-articular manifestations may be different: lesions of the eyes, skin, mucous membranes, urogenital or gastrointestinal tract. First-line drugs in the treatment of ReA are NSAIDs. Patients with an active source of infection also require a long-term treatment with antibacterial therapy, sulfosalazine is added in case of a chronic arthritis. The article presents a clinical case of Yersiniosis reactive arthritis, emphasizes the multidisciplinary approach in the management of the patient.

Article Details

How to Cite
Ivashkivskyi, O., T. Karasevska, M. Dzhus, and H. Novytska. “Yersinosis-Related Reactive Arthritis: Diagnostic and Treatment Constraints (individual Experience)”. PAIN, JOINTS, SPINE, vol. 10, no. 4, Nov. 2020, pp. 181-5, doi:10.22141/2224-1507.10.4.2020.220458.
Clinical Case


Braun J, Kingsley G, van der Heijde D, Sieper J. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999. J Rheumatol. 2000 Sep;27(9):2185-92.

Ahvonen P, Sievers K, Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand. 1969;15(3):232-53.

Vasylieva NA, Leheza KM, Ivakhiv OL, Vyshnevska NYu. Sporadic yersyniosis: difficulties of diagnostics and treatment. Infectious Diseases. 2012;(4):59-62. (in Ukrainian).

V’jalyh ZhE, Jakovenko TB, Drobot OV. Serological affiliation of Yersinia enterocolitica strains isolated from various objects on the territory of Ukraine. Profilaktychna medycyna. 2009;(8):36-38. (in Ukrainian).

Dubinskaya GM, Ryabokon' EV. Clinical description of generalization form of intestinal iersiniosis. Patologia. 2009;6(1):105-106. (in Ukrainian).

Domashenko OM. Generalizovani formy jersyniozu i psevdotuberkul'ozu: kliniko-patogenetychni ta epidemiologichni osoblyvosti, optymizacija likuvannja. Diss. dokt. med. nauk [Generalized forms of yersiniosis and pseudotuberculosis: clinical, pathogenetic and epidemiological features, optimization of treatment. Dr. med. sci. diss.]. Kyiv; 2009. 36 p. (in Ukrainian).

Sobao Y, Tsuchiya N, Takiguchi M, Tokunaga K. Overlapping peptide-binding specificities of HLA-B27 and B39. Arthritis Rheum. 1999;42(1):175-181.;2-7.

Sibilia J, Limbach FX. Reactive arthritis or chronic infectious arthritis? Ann Rheum Dis. 2002 Jul;61(7):580-587.

Cohen ES, Bodmer HC. Cytotoxic T lymphocytes recognize and lyse chondrocytes under inflammatory, but not non-inflammatory conditions. Immunology. 2003 May;109(1):8-14.

Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev. 2004 Apr;17(2):348-69.